Judith Klimovsky V. - 01 Jul 2021 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC

Role
Director
Signature
/s/ Richard A. Fair, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Jul 2021
Net transactions value
$0
Form type
4
Filing time
06 Jul 2021, 20:31:27 UTC
Previous filing
07 Jul 2021
Next filing
06 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Restricted Stock Units Award $0 +566 $0.000000 566 01 Jul 2021 Common Stock 566 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.